Sign In
Buy BDX
$170.12
-0.0900 (-0.0529%)
At Close: Aug 04, 2026
Cardiovascular Systems (CSII) Q4 Earnings, Revenues Miss Mark
01:09pm, Monday, 08'th Aug 2022 Zacks Investment Research
According to Cardiovascular Systems (CSII), strong sequential growth in each of its segments is due to procedure recovery, focused commercial strategies and the launch of products.
Nevro (NVRO) Q2 Earnings Beat Estimates, FY22 View Revised
04:58pm, Friday, 05'th Aug 2022 Zacks Investment Research
Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q2, partly owing to robust domestic performance.
QuidelOrtho (QDEL) Q2 Earnings Miss, Provides FY22 View
04:57pm, Friday, 05'th Aug 2022 Zacks Investment Research
QuidelOrtho's (QDEL) robust performance across majority of its business units and geographies drives its second-quarter 2022 top line.
AMN Healthcare (AMN) Q2 Earnings, Revenues Beat Estimates
04:56pm, Friday, 05'th Aug 2022 Zacks Investment Research
AMN Healthcare's (AMN) robust Q2 results demonstrate its segmental strength.
Should You Really Care About This Company's Short-Term Success?
10:00am, Friday, 05'th Aug 2022 The Motley Fool
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
Should You Really Care About This Company's Short-Term Success?
06:00am, Friday, 05'th Aug 2022
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
BD (BDX) Beats on Q3 Earnings and Revenues, Raises FY22 View
04:28pm, Thursday, 04'th Aug 2022 Zacks Investment Research
The majority of BD's (BDX) core units witness strong revenue growth in the fiscal third quarter.
Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates
11:45am, Thursday, 04'th Aug 2022 Zacks Investment Research
Becton Dickinson (BDX) delivered earnings and revenue surprises of 6.83% and 4.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Becton Dickinson and Co (BDX) CEO Thomas Polen on Q3 2022 Results - Earnings Call Transcript
11:40am, Thursday, 04'th Aug 2022
Becton Dickinson and Co (NYSE:BDX ) Q3 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Francesca DeMartino - SVP & Head, IR Thomas Polen - President, CEO & Chairman Christ
Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates
09:02am, Thursday, 04'th Aug 2022
Becton Dickinson (BDX) delivered earnings and revenue surprises of 6.83% and 4.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical Device Stocks Earnings on Aug 4: BDX, ABMD, AMN & DOCS
12:25pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
The Medical Device companies' Q2 results are likely to reflect strength in customer demand. Let's see how BDX, ABMD, AMN and DOCS are placed ahead of their earnings releases.
Zacks Industry Outlook Highlights Becton, Dickinson and Company, Patterson Companies and SmileDirectClub
01:02pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Becton, Dickinson and Company, Patterson Companies and SmileDirectClub are part of Zacks Industry Outlook article.
BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?
12:31pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Continued strength in BD's (BDX) Interventional segment is expected to have driven up Q3 sales.
Becton, Dickinson and Company Is A Hold At The Current Valuation
07:16am, Tuesday, 02'nd Aug 2022
Becton, Dickinson and Company is one of my favorite dividend growth investments. I am constantly looking for opportunities to add to my position.
3 Dental Supplies Stocks to Buy Amid Industry Headwinds
02:43pm, Monday, 01'st Aug 2022 Zacks Investment Research
Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, PDCO and SDC.
